蚂蚁阿福概念集体爆发，龙头股一个月接近翻倍

Core Viewpoint - The AI healthcare and pharmaceutical sector is experiencing a significant surge, with multiple stocks hitting their daily limit up, particularly those related to "Ant Group's Aifuku" [1] Group 1: Stock Performance - Several stocks in the sector, including Huaren Health and Sichuang Medical, have reached the daily limit up of 20% [1] - Meinian Health and Dian Diagnostics have recorded their third consecutive limit up, while many other stocks like Weining Health have seen increases of over 10% [1] - Huaren Health's stock price has nearly doubled, Weining Health has risen over 80%, and Meinian Health has increased by over 50% since the launch of Aifuku [1] Group 2: Market Drivers - The core driving force behind this market trend is the clear confirmation of industry trends, particularly following the launch of Ant Group's AI health assistant, Aifuku, which has surpassed 30 million monthly active users and over 10 million daily inquiries [1] - The launch of OpenAI's health feature "ChatGPT Health" on January 8 further indicates a strong belief among leading AI companies in the health AI sector [1] - Companies in the healthcare sector that have established mature scenarios and formed ecological partnerships with leading AI applications are expected to benefit from this industrial wave [1]